Poster Session
Vasculitis
Poster Session A
Irene Carrión-Barberà, MD, PhD
University of Washington
Seattle, WA, United States
Disclosure(s): AstraZeneca: Consultant (Terminated, September 24, 2024), Grant/Research Support (Terminated, September 24, 2024), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated, September 24, 2024); Bristol-Myers Squibb(BMS): Grant/Research Support (Terminated, September 24, 2024), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated, September 24, 2024), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated, September 24, 2024); Eli Lilly: Grant/Research Support (Terminated, September 24, 2024), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated, September 24, 2024); Gebro: Grant/Research Support (Terminated, September 25, 2024); GlaxoSmithKlein(GSK): Consultant (Terminated, September 24, 2024), Grant/Research Support (Terminated, September 24, 2024), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated, September 24, 2024); Janssen: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated, September 24, 2024); Merck/MSD: Grant/Research Support (Terminated, September 24, 2024); NordicPharma: Grant/Research Support (Terminated, September 24, 2024), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated, September 24, 2024); Otsuka: Grant/Research Support (Terminated, September 24, 2024); Sanofi: Grant/Research Support (Terminated, September 24, 2024), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated, September 24, 2024); UCB: Grant/Research Support (Terminated, September 24, 2024), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated, September 24, 2024)